December 2014

12 Dec

42

Five Questions with Bill Niland, Harpoon Medical CEO

In All, Portfolio

By Scott Dance, The Baltimore Sun Within a year and a half of launching as a startup, Harpoon Medical’s heart surgery device could be used on humans for the first time in a matter of weeks. The Kent Island-based company expects doctors in Poland to…

02 Dec

133

Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs

In Portfolio

Crestwood, KY – December 2nd 2014 – Apellis Pharmaceuticals, Inc., a leading biotechnology company applying immunotherapy to autoimmune disease, today announced that it has completed a $33M private placement of its Series C Preferred Stock. The financing was led by Morningside Ventures and AJU IB…

02 Dec

128

Scottish Synthetic Bone Graft Company Secures $4.8m Funding

In Portfolio

EDINBURGH, UK, December 2, 2014 –  SIRAKOSS, an innovative medical device company based in Edinburgh and Aberdeen today announced it has secured $4.8m (£3.1m) in Series-A financing from a syndicate of investors led by Epidarex Capital. Synthetic bone grafts are used in trauma, spinal and…